These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7624922)
1. Determination of droloxifene and two metabolites in serum by high-pressure liquid chromatography. Lien EA; Anker G; Lønning PE; Ueland PM Ther Drug Monit; 1995 Jun; 17(3):259-65. PubMed ID: 7624922 [TBL] [Abstract][Full Text] [Related]
2. Determination of tamoxifen and four metabolites in serum by low-dispersion liquid chromatography. Lien EA; Ueland PM; Solheim E; Kvinnsland S Clin Chem; 1987 Sep; 33(9):1608-14. PubMed ID: 3621560 [TBL] [Abstract][Full Text] [Related]
3. Sensitive method for the quantitation of droloxifene in plasma and serum by high-performance liquid chromatography employing fluorimetric detection. Tess DA; Cole RO; Toler SM J Chromatogr B Biomed Appl; 1995 Dec; 674(2):253-60. PubMed ID: 8788154 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of the anti-oestrogen droloxifene in female human subjects. John BA; Brodie RR; Baldock GA; McBurney A; Chasseaud LF; Jank P; Von Nieciecki A Xenobiotica; 2002 Aug; 32(8):699-713. PubMed ID: 12296990 [TBL] [Abstract][Full Text] [Related]
5. Stereoselective determination of unchanged and glucuroconjugated eliprodil, a new anti-ischaemic drug, in human plasma and urine by precolumn derivatization and column-switching high-performance liquid chromatography with fluorescence detection. Malavasi B; Ripamonti M; Rouchouse A; Ascalone V J Chromatogr A; 1996 Apr; 729(1-2):323-33. PubMed ID: 9004957 [TBL] [Abstract][Full Text] [Related]
6. Selected reaction monitoring LC-MS determination of idoxifene and its pyrrolidinone metabolite in human plasma using robotic high-throughput, sequential sample injection. Onorato JM; Henion JD; Lefebvre PM; Kiplinger JP Anal Chem; 2001 Jan; 73(1):119-25. PubMed ID: 11195494 [TBL] [Abstract][Full Text] [Related]
7. Determination of panomifene in human plasma by high-performance liquid chromatography. Erdélyi-Tóth V; Pap E; Kralovánszky J; Bojti E; Klebovich I J Chromatogr A; 1994 May; 668(2):419-25. PubMed ID: 8032491 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of droloxifene and its metabolites in breast cancer patients. Grill HJ; Pollow K Am J Clin Oncol; 1991; 14 Suppl 2():S21-9. PubMed ID: 1962593 [TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol in human plasma using high-performance liquid chromatography. Taras TL; Wurz GT; Hellmann-Blumberg U; DeGregorio MW J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):163-71. PubMed ID: 10202969 [TBL] [Abstract][Full Text] [Related]
10. Direct determination of tamoxifen and its four major metabolites in plasma using coupled column high-performance liquid chromatography. Fried KM; Wainer IW J Chromatogr B Biomed Appl; 1994 May; 655(2):261-8. PubMed ID: 8081472 [TBL] [Abstract][Full Text] [Related]
11. Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry. Gjerde J; Kisanga ER; Hauglid M; Holm PI; Mellgren G; Lien EA J Chromatogr A; 2005 Jul; 1082(1):6-14. PubMed ID: 16038189 [TBL] [Abstract][Full Text] [Related]
12. The effect of droloxifene and estrogen on thyroid function in postmenopausal women. Marqusee E; Braverman LE; Lawrence JE; Carroll JS; Seely EW J Clin Endocrinol Metab; 2000 Nov; 85(11):4407-10. PubMed ID: 11095487 [TBL] [Abstract][Full Text] [Related]
13. Preclinical data for Droloxifene. Hasmann M; Rattel B; Löser R Cancer Lett; 1994 Sep; 84(2):101-16. PubMed ID: 8076367 [TBL] [Abstract][Full Text] [Related]
14. Sensitive HPLC-PDA determination of tamoxifen and its metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in human plasma. Antunes MV; Rosa DD; Viana Tdos S; Andreolla H; Fontanive TO; Linden R J Pharm Biomed Anal; 2013 Mar; 76():13-20. PubMed ID: 23291438 [TBL] [Abstract][Full Text] [Related]
15. Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer. Langan-Fahey SM; Tormey DC; Jordan VC Eur J Cancer; 1990; 26(8):883-8. PubMed ID: 2145931 [TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic method for the determination of toremifene and its major human metabolites. Webster LK; Crinis NA; Stokes KH; Bishop JF J Chromatogr; 1991 Apr; 565(1-2):482-7. PubMed ID: 1831461 [TBL] [Abstract][Full Text] [Related]
17. Comparison between liquid chromatography-time of-flight mass spectrometry and selected reaction monitoring liquid chromatography-mass spectrometry for quantitative determination of idoxifene in human plasma. Zhang H; Henion J J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(1):151-9. PubMed ID: 11419740 [TBL] [Abstract][Full Text] [Related]
18. Induction of transforming growth factor beta by the antiestrogens droloxifene, tamoxifen, and toremifene in MCF-7 cells. Knabbe C; Zugmaier G; Schmahl M; Dietel M; Lippman ME; Dickson RB Am J Clin Oncol; 1991; 14 Suppl 2():S15-20. PubMed ID: 1835818 [TBL] [Abstract][Full Text] [Related]
19. Pharmacologic and biologic properties of droloxifene, a new antiestrogen. Eppenberger U; Wosikowski K; Küng W Am J Clin Oncol; 1991; 14 Suppl 2():S5-14. PubMed ID: 1962598 [TBL] [Abstract][Full Text] [Related]
20. Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease. van der Geest R; Kruger P; Gubbens-Stibbe JM; van Laar T; Bodde HE; Danhof M J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):131-41. PubMed ID: 9449564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]